Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

University of York chemist takes carbohydrate blue riband

04.10.2005


A University of York scientist has won the world’s most prestigious award for the excellence of his research into carbohydrates.



The International Carbohydrate Organization is to present the Roy L Whistler International Award for 2006 to Professor Gideon Davies, of the University’s Department of Chemistry.

Professor Davies is only the second UK-based scientist to win the award, which recognises scientists "who have made contributions of excellence in carbohydrate chemistry and biochemistry and with promise of continuing significant contributions." It was established in 1984 in honour of Professor Roy L.Whistler.


Professor Davies will receive the accolade at the XXIII International Carbohydrate Symposium at Whistler, British Columbia, Canada in July, next year, where he will present the opening lecture. His research centres on the study of the structure and mechanisms of action of enzymes that catalyse the synthesis and breakdown of carbohydrates. Many proteins only acquire their unique characteristics by working in conjunction with carbohydrates and an understanding of this relationship will be crucial in new advances in medicine.

Professor Davies currently has exciting on-going work on topics ranging from the bacteria that causes the "flesh-eating" disease necrotizing fasciitis to the enzymes responsible for the colour of red wine. Enzymes that break down carbohydrates are essential to digestion, but also, for instance, in biological washing powders and in environmentally friendly routes to waste product breakdown as an alternative to landfill and fossil fuels. Professor Davies, 41, who leads a ten-strong research group based in the University’s Structural Biology Laboratory said: "I knew I had been nominated for this award, but it was a huge surprise when I was told that I had actually won." He graduated in Biochemistry in 1985 at the University of Bristol, where he also studied for his PhD on the molecular biology, structure and mechanism of glycolytic enzymes. In 1990, he moved to the European Molecular Biology Laboratory, and later joined the Department of Chemistry at York.

While working on ’carbohydrate-active’ enzymes at York, Professor Davies made extended study visits to work in France, Sweden and Canada, He took up a Royal Society University Research Fellowship at York in 1996. He was made a full professor of the University of York in 2001 and received a University of York ’Anniversary Chair’ in 2004. He is a double award winner of the Royal Society of Chemistry.

David Garner | alfa
Further information:
http://www.york.ac.uk/admin/presspr/pressreleases/whistleraward.htm

More articles from Life Sciences:

nachricht The interactome of infected neural cells reveals new therapeutic targets for Zika
23.01.2017 | D'Or Institute for Research and Education

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

Quantum optical sensor for the first time tested in space – with a laser system from Berlin

23.01.2017 | Physics and Astronomy

The interactome of infected neural cells reveals new therapeutic targets for Zika

23.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>